← Back to all trials
Enrolling By Invitation
NCT05697861
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Conditions: Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Wild-Type Transthyretin Cardiac Amyloidosis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 72
Sponsor: Intellia Therapeutics
Location: Clinical Trial Site Paris
Summary
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Eligibility Criteria
Inclusion Criteria:
1. A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received.
2. A subject has provided informed consent for the LTFU study.
Exclusion Criteria:
None
Source: ClinicalTrials.gov (NCT05697861). StuddyBuddy aggregates publicly available trial information.
